THC Tolerance Appeared After Dosing Outside a Shuttle-Box Task in Rats

A 1977 rat experiment found shuttle-box tolerance even in animals that initially received THC after testing. That comparison suggested tolerance was not dependent entirely on practicing the task while intoxicated.

Drug timing distinguished the groups

Both groups trained in the shuttle box, but one received THC before sessions and the other afterward. The before-session group developed tolerance to response inhibition within several sessions. The after-session animals also appeared tolerant when later challenged with THC before testing.

A physiological interpretation was supported, not proved exclusive

The authors interpreted the transfer as evidence for a physiological basis rather than solely learned tolerance. It does not establish that task experience never matters, because both groups still trained and other experiments can ask different questions. The result addresses a specific requirement for drug-state practice in this task.

Temperature supplied an additional comparison

All animals also developed tolerance to THC-related hypothermia. Agreement between a physiological endpoint and the task result supports adaptation beyond one learned response, while not showing that all functions recover together or share one molecular mechanism.

The study helps separate repeated drug exposure from repeated performance under the drug. Its findings do not guarantee normal performance in humans or refute all context-dependent tolerance. Task type, dosing sequence and challenge conditions define the conclusion.

Related: interpreting cannabis tolerance claims.

Research cited

ten Ham M. Tolerance to the effects of delta9-THC on shuttle-box performance and body temperature. Pharmacology, biochemistry, and behavior (1977). doi:10.1016/0091-3057(77)90071-5. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Psychiatric CBD Review’s Recommendation Grades Included Both CBD and THC-Containing Nabiximols

A review published in 2020 graded psychiatric evidence from studies of CBD and CBD-containing nabiximols. Its recommendation labels should not be quoted as though every underlying intervention was purified CBD or every study was randomized. The included designs ranged widely The review identified 23 relevant studies spanning case reports, case…

Spread the love

Read Article: A Psychiatric CBD Review’s Recommendation Grades Included Both CBD and THC-Containing Nabiximols

CBD Eye Research: Molecular Targets and Clinical Ocular Treatment Are Different Evidence Levels

A 2021 ocular CBD review brought together in-vitro and in-vivo research, proposed molecular targets and possible therapeutic applications. This evidence maps a development pathway; it does not establish that CBD products are effective eye treatments. The experimental system belongs in the conclusion A cellular result can identify a target or…

Spread the love

Read Article: CBD Eye Research: Molecular Targets and Clinical Ocular Treatment Are Different Evidence Levels

CBD Addiction Research Measures Reinforcement, Motivation and Withdrawal as Different Outcomes

A 2021 review evaluated CBD research on reinforcing, motivational and withdrawal-related drug effects. These outcomes can inform substance-use-disorder research, but an improvement in one cannot establish successful treatment across all of them. The source combined preclinical and clinical reports The review covered alcohol, opioids, cannabinoids, nicotine and psychostimulants. An animal…

Spread the love

Read Article: CBD Addiction Research Measures Reinforcement, Motivation and Withdrawal as Different Outcomes

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us